Advanced search

Maëlys Castella is the founder of AminonaConsulting BV.
She currently holds positions as an Independent Director at Société BIC SA, UCB SA, BIC USA, Inc., and C&A Europe SA. Her former positions include Director at Akzonobel Art Foundation, Chief Financial Officer at Akzo Nobel NV, Group Deputy Chief Financial Officer at Air Liquide Finland Oy and Air Liquide BV, and Head-Investor Relations & Controller at Elf Group Ltd.
She has also served as Chief Financial Officer at Akzo Nobel Ltda.
Castella has a graduate degree from the University of Pennsylvania, an undergraduate degree from École Centrale Paris, and a graduate degree from IFP School.

Jean-François Castella has worked as a Director at Infotel Corp.
and as a Vice President-Software at Infotel SA.

Paul Castella is the founder of Bio2 Medical, Inc. (founded in 2006) where he holds the title of Director.
He is also the founder of ViroXis Corp.
(founded in 2006) and Aeon Bioscience, Inc. (founded in 2007) where he holds the titles of Director and Chief Business Officer respectively.
In 2020, he founded Hera Biotech, Inc. where he currently serves as Chairman.
Dr. Castella is also the founder of Targeted Technology Ventures LLC.
Currently, Dr. Castella holds positions as Chairman at BioDtech, Inc., Director at StemBioSys, Inc., Director at Innovative Trauma Care, Inc., Director at CytoBioscience, Inc., and Senior Managing Partner at Incyte Venture Partners LLC (since 2013).
Dr. Castella's former positions include Chief Executive Officer & Director at InventaBiotech, Inc. and President & Chief Financial Officer at CardioSpectra, Inc.Dr. Castella's education includes an undergraduate degree from the University of London (1987), an MBA from The University of Texas at Austin (2005), and a doctorate from Weill Cornell Medical College.